MedPath

Treatment of Thalassemia Major by Ayurveda

Phase 2
Completed
Conditions
Health Condition 1: null- Diagnosed cases of Thalassemia Major
Registration Number
CTRI/2017/03/008174
Lead Sponsor
Director IPGT and RA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
44
Inclusion Criteria

Diagnosed cases of Thalassemia Major

Exclusion Criteria

Children below 01 year and above 10 years of age

Patients having HIV HBV infection hepatic failure DM TB etc

Patient having BT interval for less than 12 days

Patient undergone splenectomy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Establish an adjuvant therapy from ayurveda in order to 1 Prolonging the BT interval 2 Decrease the serum ferritin level 3 Enhance the life span of the thalassemic children 4 Increase the QOL of thalassemic patients 5 Minimise complication such as iron overloading pain etc <br/ ><br> <br/ ><br>Timepoint: Special investigations will be carried out before and after treatment for duration of 6 months <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Enhance the life span of the thalassemic children Increase the QOL of thalassemic patients <br/ ><br>Timepoint: 18 months <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath